To include your compound in the COVID-19 Resource Center, submit it here.

Axovant falls as CEO, president depart

Axovant Sciences Ltd. (NASDAQ:AXON) fell $0.38 (20%) to $1.54 on Monday after it shuffled its management

Read the full 164 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE